<DOC>
	<DOCNO>NCT01505049</DOCNO>
	<brief_summary>Vaccines human papillomavirus ( HPV ) available United States since 2006 . Early study show high rate effectiveness vaccine , however know long protection last . The IMAP study look various part immune system potential marker long live immune response vaccine .</brief_summary>
	<brief_title>Immune Memory After Papillomavirus Vaccination</brief_title>
	<detailed_description>Three group patient recruit study . One group woman complete three vaccination . The second group woman overdue final vaccination . We also recruit woman vaccinate previously .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Female age 1826 inclusive ( 1830 woman previously vaccinate 2 . If sexually active enrol unvaccinated group , must use reliable form birth control first seven month study . For purpose protocol reliable form hormonal barrier contraception . Intrauterine device history sterilization also consider reliable form birth control . Abstaining sex also reliable form contraception . 3 . Able give inform consent 4 . Negative urine pregnancy test enrollment 1 . Currently pregnant , breast feeding planning pregnancy 2 . Underlying immunological disease , previously diagnose HIV infection history transplantation , history splenectomy 3 . Use medication potential immunological effect systemic corticosteroid chemotherapy 4 . Prior therapy cervical dysplasia cervical cancer loop excision , laser ablation , cryotherapy hysterectomy 5 . Unable comply protocol 6 . Severe allergic reaction ( e.g. , anaphylaxis ) previous vaccine dose vaccine component 7 . An acute illness , include oral temperature 100.4 degree F within three day visit specific exclusion may apply one three cohort</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>immunology</keyword>
	<keyword>vaccination</keyword>
	<keyword>human papillomavirus</keyword>
</DOC>